Sudar Alagarsamy

Sudar Alagarsamy, PhD, PMP, currently serves as Executive Director of Program Management at Arrowhead Pharmaceuticals since July 2020. Previously, Sudar held the position of Senior Director of Program Management at Mirati Therapeutics from September 2018 to May 2020, and various leadership roles at Pfizer from September 2013 to September 2018, including Director of Project Management for Early Oncology and Biosimilars. Earlier experience includes serving as Director of Project Management at Valeant Pharmaceuticals (now Bausch Health Companies) and Project Director at Ferring Pharmaceuticals, where Sudar led multiple programs in R&D and commercial launches. The career began as a Senior Scientist at Ferring Research Institute and included a post-doctoral fellowship in CNS Pharmacology at Emory University. Sudar holds a PhD in Neuroscience from The University of Texas Medical Branch and a BS/BA in Biochemistry/Biology from Trinity University.